Premenstrual Syndrome Market Growth, Trends, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Premenstrual Syndrome Market covers analysis by : Treatment Type (Painkillers, Oral contraceptive pills, Estrogen-only patches and implants, Gonadotropin-releasing hormone (GnRH) analogues, Selective serotonin reuptake inhibitors (SSRIs)), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Dec 2025
  • Report Code : TIPRE00008488
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Page Updated: Apr 2025

The Premenstrual Syndrome Market is expected to register a CAGR of 6% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The Premenstrual Syndrome Market report covers segmental analysis by Treatment Type (Painkillers, Oral contraceptive pills, Estrogen-only patches and implants, Gonadotropin-releasing hormone (GnRH) analogues, Selective serotonin reuptake inhibitors (SSRIs)), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken down at the regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.

Purpose of the Report

The report Premenstrual Syndrome Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Premenstrual Syndrome Market Segmentation

Treatment Type

  • Painkillers
  • Oral contraceptive pills
  • Estrogen-only patches and implants
  • Gonadotropin-releasing hormone analogues
  • Selective serotonin reuptake inhibitors

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Premenstrual Syndrome Market: Strategic Insights

premenstrual-syndrome-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Premenstrual Syndrome Market Growth Drivers

  • Rising Awareness and Diagnosis of Premenstrual Syndrome: The increasing awareness about Premenstrual Syndrome (PMS) among women globally has led to better recognition and diagnosis of the condition. With more women understanding the symptoms, they are seeking medical advice and treatment, driving the demand for PMS-related products and services. As awareness campaigns continue to grow, more individuals are being educated on PMS, further expanding the market reach.
  • Increasing Female Population in Reproductive Age: A larger segment of the population falling within the reproductive age group, particularly in emerging economies, contributes to a higher prevalence of Premenstrual Syndrome. The growing number of women in their menstruating years directly correlates to an expanded customer base for PMS management solutions. This demographic shift presents a key opportunity for pharmaceutical companies and health product manufacturers in the PMS market.
  • Development of Natural and Herbal Remedies: As consumers increasingly prefer natural and organic products, the Premenstrual Syndrome market is witnessing a surge in the demand for herbal remedies, supplements, and alternative treatments. Natural ingredients like magnesium, vitamin B6, and herbal teas are gaining popularity for their perceived benefits in alleviating PMS symptoms. The growing trend towards holistic health and wellness is expected to continue driving market growth in the coming years.

Premenstrual Syndrome Market Future Trends

  • Rising Focus on Women's Health: There has been a heightened focus on women’s health, with increasing attention being paid to issues such as menstruation, menopause, and PMS. Governments, NGOs, and private organizations are advocating for better healthcare options for women. This societal focus on women’s health is propelling investments into the PMS market and fostering the development of a variety of new products and services.
  • Lifestyle Factors Contributing to PMS Symptom Severity: The modern lifestyle, characterized by high stress, poor diet, and lack of physical activity, is exacerbating PMS symptoms for many women. As these factors intensify the severity of symptoms like mood swings, fatigue, and irritability, the need for effective treatment solutions in the PMS market grows. Companies are responding by creating symptom-specific solutions to address these lifestyle-related challenges.
  • Improved Accessibility to PMS Products: With the rise of e-commerce and online healthcare services, Premenstrual Syndrome (PMS) treatments have become more accessible to a wider audience. Women now have access to a broad range of over-the-counter medications, supplements, and symptom-relief devices via online platforms, increasing convenience and fueling market growth. This digital shift also allows for the expansion of market reach to rural or underserved populations.

Premenstrual Syndrome Market Opportunities

  • Partnerships with Wellness and Lifestyle Brands: Collaborations between PMS market players and wellness, lifestyle, or fitness brands can create new avenues for product development and marketing. By integrating PMS relief solutions into broader health and wellness initiatives—such as fitness programs, mindfulness apps, and holistic wellness retreats—companies can effectively expand their customer base. These partnerships also allow for cross-promotional strategies that reach health-conscious women who may not otherwise consider PMS-specific treatments.
  • Creating Eco-Friendly and Sustainable PMS Products: Sustainability is a growing trend across industries, and the PMS market is no exception. Women are increasingly interested in eco-friendly, sustainable products, including organic cotton pads, biodegradable feminine hygiene products, and natural supplements. Companies that embrace eco-conscious production methods and materials can tap into the environmentally aware consumer segment, providing them with sustainable PMS solutions while enhancing brand reputation.
  • Catering to the Menstrual Health Needs of Adolescents: Focusing on the PMS needs of adolescent girls presents a unique opportunity within the PMS market. While PMS is more commonly associated with adult women, many young girls experience early signs of menstrual discomfort. Developing products and educational resources aimed at this demographic can help build long-term customer loyalty, as well as promote early intervention and better management of PMS symptoms.

Premenstrual Syndrome Market Regional Insights

The regional trends and factors influencing the Premenstrual Syndrome Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Premenstrual Syndrome Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Premenstrual Syndrome Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031)6%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Treatment Type
  • Painkillers
  • Oral contraceptive pills
  • Estrogen-only patches and implants
  • Gonadotropin-releasing hormone analogues
  • Selective serotonin reuptake inhibitors
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Alva-Amco Pharmacal Cos., Inc
  • Bayer, Inc.
  • Bristol-Myers Squibb Company
  • Chattem, Inc. (Sanofi)
  • DEKK-TEC, Inc.
  • GlaxoSmithKline Plc
  • MetP Pharma AG
  • Novartis AG
  • Pherin Pharmaceuticals, Inc.
  • Umecrine Mood AB

Premenstrual Syndrome Market Players Density: Understanding Its Impact on Business Dynamics

The Premenstrual Syndrome Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


premenstrual-syndrome-market-cagr

  • Get the Premenstrual Syndrome Market top key players overview

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Premenstrual Syndrome Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Premenstrual Syndrome Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

1

What is the expected CAGR of the Premenstrual Syndrome Market?

The Premenstrual Syndrome Market is expected to register a CAGR of 6% from 2025-2031.
2

What are the driving factors impacting the Premenstrual Syndrome Market?

The major factors impacting the Premenstrual Syndrome Market are: Rising Awareness and Diagnosis of Premenstrual Syndrome, Increasing Female Population in Reproductive Age and Development of Natural and Herbal Remedies
3

What are the future trends in the Premenstrual Syndrome Market?

Key future trends in this market are - Rising Focus on Women's Health, Lifestyle Factors Contributing to PMS Symptom Severity and Improved Accessibility to PMS Products
4

Which are the key players in the Premenstrual Syndrome Market?

Key companies of this market are: Alva-Amco Pharmacal Cos., Inc, Bayer, Inc., Bristol-Myers Squibb Company, Chattem, Inc. (Sanofi), DEKK-TEC, Inc., GlaxoSmithKline Plc, MetP Pharma AG, Novartis AG, Pherin Pharmaceuticals, Inc., Umecrine Mood AB
5

What are the deliverable formats of Premenstrual Syndrome Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
6

What are the options available for the customization of this report?

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Our Clients
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
ISO Certified Logo